Bid Price | 150.00p | High Price | 156.18p |
---|
Ask Price | 156.50p | Low Price | 150.25p |
---|
Open Price | 155.99p | Spread | 4.15% |
---|
Prev Close | 153.25p | Volume | 91,796 |
---|
Hemogenyx Pharmaceuticals PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Jul 4, 2025 | 155.99 | 156.18 | 150.25 | 153.25 | 91,796 |
Jul 3, 2025 | 156.50 | 156.50 | 150.00 | 153.25 | 8,279 |
Jul 2, 2025 | 150.51 | 156.18 | 150.51 | 153.25 | 30,048 |
Jul 1, 2025 | 150.51 | 156.18 | 150.51 | 153.25 | 25,856 |
Jun 30, 2025 | 150.33 | 157.00 | 150.00 | 153.25 | 42,815 |
More Hemogenyx Pharmaceuticals PLC Historic Prices >Hemogenyx Pharmaceuticals PLC Information
Name | Hemogenyx Pharmaceuticals PLC | Index | |
---|
ISIN | GB00BQVXM815 | Epic | HEMO |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | SET3 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 1,500 | Trading Status | Closed |
---|
Shares in Issue | 4.59 m | Prev Close | 153.25p |
---|
PE Ratio | | Market Cap | £7.04 m |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | -£1.01 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | -0.572635 | DPS Growth (%) | 0 |
---|
Current Ratio | 0.724158 | Quick Ratio | 0.140709 |
---|
Hemogenyx Pharmaceuticals PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
13/06/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
14/05/25 | PLAC | Vladislav Sandler | CEO | 250,000 @ £1.81 | £451,250.00 |
30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ £0.02 | £10,000.00 |
03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ £0.00 | £0.00 |
12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ £0.02 | £4,200.00 |
07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ £0.02 | £635.00 |
11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ £0.03 | £11,840.00 |
10/10/17 | BUY | Peter Redmond | NED | 155,000 @ £0.03 | £4,859.00 |
10/10/17 | BUY | Adrian Thorpe Beeston | RES | 317,683 @ £0.03 | £9,848.00 |
More Hemogenyx Pharmaceuticals PLC Director Deals >Hemogenyx Pharmaceuticals PLC News